Kenneth T. Mills
President and CEO at REGENXBIO Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: REGENXBIO Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
REGENXBIO Inc. May 31, 202496.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | REGENXBIO Inc. | Grant or award | +9,807 | — | — |
| Jan 27, 2026 | REGENXBIO Inc. | Option exercise | +225,000 | $13.09 | $2,945,250 |
| Jan 27, 2026 | REGENXBIO Inc. | Shares withheld for tax | −221,753 | $13.41 | $2,973,708 |
| May 30, 2025 | REGENXBIO Inc. | Grant or award | +7,768 | — | — |
| May 12, 2025 | REGENXBIO Inc. | Option exercise | +20,602 | $3.76 | $77,464 |
| May 12, 2025 | REGENXBIO Inc. | Open-market sale | −20,602 | $7.91 | $162,962 |
| Mar 27, 2025 | REGENXBIO Inc. | Option exercise | +30,752 | $3.76 | $115,628 |
| Aug 8, 2024 | REGENXBIO Inc. | Option exercise | +36,316 | $0.85 | $30,869 |
| Jul 25, 2024 | REGENXBIO Inc. | Option exercise | +15,369 | $3.76 | $57,787 |
| Jul 25, 2024 | REGENXBIO Inc. | Open-market sale | −15,369 | $13.96 | $214,551 |
| Jul 24, 2024 | REGENXBIO Inc. | Option exercise | +12,221 | $3.76 | $45,951 |
| Jul 24, 2024 | REGENXBIO Inc. | Open-market sale | −12,221 | $13.78 | $168,405 |
| Jul 17, 2024 | REGENXBIO Inc. | Option exercise | +2,210 | $3.76 | $8,310 |
| Jul 17, 2024 | REGENXBIO Inc. | Open-market sale | −2,210 | $13.77 | $30,432 |
| Jul 16, 2024 | REGENXBIO Inc. | Option exercise | +200 | $3.76 | $752 |
Questions about Kenneth T. Mills
What boards is Kenneth T. Mills on?
Kenneth T. Mills sits on the board of REGENXBIO Inc.
What company is Kenneth T. Mills the CEO of?
Kenneth T. Mills is President and CEO of REGENXBIO Inc.
How long has Kenneth T. Mills served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.